Contact
Alle persberichten
Nederlandse persberichten
English press releases
Zoeken
English press releases
02
04
11:59
IFF Opens Global Service Center in Budapest
NEW YORK–(BUSINESS WIRE)– Regulatory News: International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF) opened its new global service center in Budapest,...
Bekijk
02
04
08:55
SES Reach Grows to 355 Million Homes Worldwide
SES’s annual market research demonstrates its role in delivering video to a substantial global audience of over 1 billion people LUXEMBOURG–(BUSINESS WIRE)– SES strengthens its...
Bekijk
02
04
07:00
Thales Completes Acquisition Of Gemalto To Become A Global Leader In Digital Identity And Security
Thales (Euronext Paris: HO) has today completed the acquisition of Gemalto (Euronext Amsterdam and Paris: GTO), creating a global leader in digital identity and security....
Bekijk
01
04
14:24
Bridgestone Europe Completes Acquisition of TomTom Telematics
Acquisition accelerates Bridgestone’s digital transformation and status as preferred partner in mobility solutions Deal reaffirms TomTom Telematics as the number one in Europe and as...
Bekijk
01
04
13:24
ABB Shows the Factory of the Future to German Chancellor and PM of Sweden
Federal Chancellor Angela Merkel and the Swedish Prime Minister Stefan Löfven were given a glimpse into the factory of the future by ABB CEO Ulrich...
Bekijk
01
04
13:00
ABB and Ericsson Join Forces to Accelerate Wireless Automation for Flexible Factories
HANNOVER, Germany–(BUSINESS WIRE)– ABB and Ericsson today strengthened their long-standing relationship with the signing of a Memorandum of Understanding (MoU) at Hannover Messe 2019. The...
Bekijk
01
04
06:56
Notice of ABB’s Annual General Meeting on May 2, 2019
ZURICH–(BUSINESS WIRE)– ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, May 2, 2019. The invitation can...
Bekijk
29
03
17:13
Elliott Statement on Telecom Italia
MILAN & LONDON–(BUSINESS WIRE)– Elliott Advisors (UK) Limited (“Elliott”) welcomes Vivendi’s decision to withdraw its request to shareholders to revoke five of Telecom Italia’s (“TIM”)...
Bekijk
29
03
14:00
Arch Announces European Brexit Changes
DUBLIN–(BUSINESS WIRE)– Arch Insurance International and Arch MI today announced changes to their European operations as part of the Arch Brexit plan and other recent...
Bekijk
29
03
13:12
Celgene Receives CHMP Positive Opinions for Both REVLIMID® (lenalidomide) and IMNOVID® (pomalidomide)-Based Triplet Combination Regimens for Patients with Multiple Myeloma
The CHMP adopted two positive opinions recommending European Commission approval of: REVLIMID in combination with bortezomib and dexamethasone (RVd) in adult patients with previously untreated...
Bekijk
29
03
13:00
Boehringer Ingelheim Enhances Oncology R&D with Novel MacroDel Delivery Technology Via Acquisition of ICD Therapeutics
New molecular platform to access intracellular targets across a broad range of tumor cell types Opens up new range of therapeutic opportunities for difficult-to-treat cancers...
Bekijk
29
03
12:44
bluebird bio Receives Positive Opinion from CHMP for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia (TDT) Who Do Not Have β0/β0 Genotype
First gene therapy recommended for approval in the EU for TDT Treatment with ZYNTEGLO has been shown to help eliminate the need for chronic blood...
Bekijk
29
03
07:00
Success of Thales Offer for Gemalto Shares
85.58% of Gemalto shares have been tendered to the Offer All Offer Conditions are now satisfied or waived, making the Offer unconditional Settlement of tendered...
Bekijk
28
03
22:04
Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients
— Filgotinib 100 mg and 200 mg Plus Methotrexate (MTX) Demonstrated Significantly Higher ACR20/50/70 Responses Than Methotrexate Alone — — Filgotinib Safety Profile Consistent With...
Bekijk
28
03
22:03
Gilead and Galapagos Announce Filgotinib Meets Primary and Key Secondary Endpoints in the Phase 3 FINCH 1 Rheumatoid Arthritis Study
— Filgotinib 100 mg and 200 mg Doses Demonstrated Significantly Higher ACR20/50/70 Responses than Placebo in Patients with Prior Inadequate Methotrexate Response — — Significant...
Bekijk
Nooooooooooovum
Page 345 of 654
Vorige
1
…
343
344
345
346
347
…
654
Volgende
Omhoog